Key result
The DELTA method measured local activation time differences <4 ms more accurately than standard LAT annotation in simulated EGMs (mean error 3.8% vs. 22.9%) and showed agreement in clinical EGMs.
Why the study?
High-resolution mapping of local conduction velocity during clinical electrophysiology procedures is limited because measuring it at small spatial scales requires local activation time difference annotations beyond the temporal resolution of standard clinical methods.
Does the DELTA method improve the accuracy of local activation time difference measurements compared to standard LAT annotation in simulated and clinical electrograms?
Does the DELTA method improve the accuracy of local activation time difference measurements compared to standard LAT annotation in simulated and clinical electrograms?
Absolute Event Rate: 3.8% vs 22.9%
The DELTA method leverages the relationship between bipolar EGM peak amplitude and activation time difference to improve measurement accuracy for small LAT differences, potentially enhancing conduction velocity mapping at small spatial scales.
May refine small-scale conduction velocity mapping in research; leaves open clinical impact on ablation outcomes.
Localized changes in myocardial conduction velocity (CV) are pro-arrhythmic, but high-resolution mapping of local CV is not yet possible during clinical electrophysiology procedures. This is in part because measurement of local CV at small spatial scales (1 mm) requires accurate annotation of local activation time (LAT) differences with very high temporal resolution (≤1 ms), beyond that of standard clinical methods. We sought to develop a method for high-resolution measurement of LAT differences and validate against existing techniques. First, we use a simplified theoretical model to identify a quantitative relationship between the LAT difference of a pair of electrodes and the peak amplitude of the bipolar EGM measured between them. This allows LAT differences to be calculated from bipolar EGM peak amplitude, by a novel “Determination of EGM Latencies by Transformation of Amplitude” (DELTA) method. Next, we use simulated EGMs from a computational model to validate this method. With 1 kHz sampling, LAT differences less than 4 ms were more accurately measured with DELTA than by standard LAT annotation (mean error 3.8% vs. 22.9%). In a 1-dimensional and a 2-dimension model, CV calculations were more accurate using LAT differences found by the DELTA method than by standard LAT annotation (by unipolar dV/dt timing). DELTA-derived LAT differences were more accurate than standard LAT annotation in simulated complex fractionated EGMs from a model incorporating fibrosis. Finally, we validated the DELTA method in vivo using 18,740 bipolar EGMs recorded from the left atrium of 10 atrial fibrillation patients undergoing catheter ablation. Using clinical EGMs, there was agreement in LAT differences found by DELTA, standard LAT annotation, and unipolar waveform cross-correlation. These results demonstrate an underlying relationship between a bipolar EGM’s peak amplitude and the activation time difference between its two electrodes. Our computational modeling and clinical results suggest this relationship can be leveraged clinically to improve measurement accuracy for small LAT differences, which may improve CV measurement at small spatial scales.
No takes yet. Share an insight, caveat, or question.
Gaeta et al. (2021) studied Atrial fibrillation (n=10). DELTA method vs. Standard LAT annotation was evaluated on Mean error of LAT differences less than 4 ms. The DELTA method measured local activation time differences <4 ms more accurately than standard LAT annotation in simulated EGMs (mean error 3.8% vs. 22.9%) and showed agreement in clinical EGMs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: